Cartesian Therapeutics (RNAC) Treasury Shares (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Treasury Shares of $736272.0 for Q1 2026, up 28.58% year-over-year from $572605.0 in Q1 2025, and up 40.91% quarter-over-quarter from $522498.0 in Q4 2025.
Cartesian Therapeutics (RNAC) Treasury Shares (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 11 years of Treasury Shares data on file, last reported at $736272.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $736272.0, up 28.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $736272.0 (up 28.58% YoY), and the FY2025 annual result was $522498.0, up 17.62% from the prior year.
- Treasury Shares grew to $736272.0 in Q1 2026 per RNAC's latest filing, from $522498.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $2.5 million in Q1 2023 and troughed at $444238.0 in Q4 2024.
- A 5-year average of $1.1 million and a median of $654438.5 in 2025 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares jumped 332.39% in 2022, then plunged 81.16% in 2024.
- A 5-year view of Treasury Shares shows it stood at $1.7 million in 2022, then rose by 20.37% to $2.1 million in 2023, then sank by 78.36% to $444238.0 in 2024, then grew by 17.62% to $522498.0 in 2025, then jumped by 40.91% to $736272.0 in 2026.
- Business Quant data shows RNAC's Treasury Shares at $736272.0 in Q1 2026, $522498.0 in Q4 2025, and $523254.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | 736,272.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 736,272.00 |
| Mar 31, 2026 | 736,272.00 |
| Dec 31, 2025 | 522,498.00 |
| Dec 31, 2025 | 522,498.00 |
| Sep 30, 2025 | 523,254.00 |
| Sep 30, 2025 | 523,254.00 |
| Jun 30, 2025 | 533,331.00 |
| Jun 30, 2025 | 533,331.00 |
| Mar 31, 2025 | 572,605.00 |
| Mar 31, 2025 | 572,605.00 |
| Dec 31, 2024 | 444,238.00 |
| Dec 31, 2024 | 444,238.00 |
| Sep 30, 2024 | 448,211.00 |
| Sep 30, 2024 | 448,211.00 |
| Jun 30, 2024 | 454,456.00 |
| Jun 30, 2024 | 454,456.00 |
| Mar 31, 2024 | 464,018.00 |
| Mar 31, 2024 | 464,018.00 |
| Sep 30, 2023 | 2.05 Mn |
| Sep 30, 2023 | 2.05 Mn |